2026 Annual Meeting | C127 - Update in Acute Seizure Management and Status Epilepticus

Date Tuesday 04/21/26

Time 07:00 AM - 09:00 AM CDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Clio A. Rubinos, MD

Topic(s) Epilepsy/Clinical Neurophysiology (EEG)

Learning Objectives Participants should be able to identify patients at high risk of status epilepticus and apply early interventions to prevent progression. The course reviews new uses of IV anesthetics like ketamine and propofol, explores advances in SE management, and highlights how EEG monitoring can be implemented effectively, even in resource-limited or rural American settings. A final interactive case discussion will reinforce key concepts through practical, real-world decision-making.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
07:00 AM - 07:05 AM CDT	Introduction	Introduction Clio A. Rubinos, MD
07:05 AM - 07:30 AM CDT	Speaker	The Missing Phase: Understanding the Pre-Status Epilepticus Stage Clio A. Rubinos, MD
07:30 AM - 07:55 AM CDT	Speaker	Anesthetic Treatment in Status Epilepticus: What’s New Maysaa M. Basha, MD, FAAN
07:55 AM - 08:20 AM CDT	Speaker	Routine vs Continuous EEG in Status Epilepticus: Clinical Impact, Practical Challenges, and Global Considerations Melody T. Asukile, MBBS
08:20 AM - 08:35 AM CDT	Q&A	Questions and Answers Clio A. Rubinos, MD, Melody T. Asukile, MBBS, Maysaa M. Basha, MD, FAAN
08:35 AM - 09:00 AM CDT	Discussion	Status Epilepticus in Motion: A Case-Based Integration Clio A. Rubinos, MD, Melody T. Asukile, MBBS, Maysaa M. Basha, MD, FAAN

Faculty Disclosures
Clio A. Rubinos, MD	Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Azurity Pharmaceuticals. Dr. Rubinos has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Marinus Pharmaceutical. Dr. Rubinos has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for American Epilepsy Society . The institution of Dr. Rubinos has received research support from University of North Carolina .
Melody T. Asukile, MBBS	Dr. Asukile has received research support from Royal Society for Tropical Medicine and Hygiene. The institution of Dr. Asukile has received research support from Leverhulme Trust. Dr. Asukile has received personal compensation in the range of $0-$499 for serving as a meeting speaker with American Neurological Association.
Maysaa M. Basha, MD, FAAN	Dr. Basha has nothing to disclose.

��ɫ��

��ɫ��